Cognitive Training Using Feuerstein Instrumental Enrichment (Feuerstein)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02774083|
Recruitment Status : Completed
First Posted : May 17, 2016
Last Update Posted : September 24, 2019
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
Background: The Feuerstein Instrumental Enrichment Program was designed to prevent mental deterioration and preserve cognitive abilities among people aged 60 and above. The program is an applied practicable program based on the theories of Structural Cognitive Modifiability as well as on a Mediated Learning Experience. The program takes into consideration the unique characteristics and requirements of the older population. The program is composed of a variety of cognitive tasks that offer systematic activities intended to stimulate mental and cognitive development.
Objective: To examine the influence of the Feuerstein Program on the cognitive function and well-being of participants suffering from Mild Cognitive Impairment (MCI).
Hypothesis: The Feuerstein Program will improve cognitive abilities and functional well-being of the participants.
Methods: Residents of retirement homes will be offered to participate in the research. Participants will undergo cognitive and functional assessments that will be carried out on four specific dates. The participants of the Intervention Group will participate in the Feuerstein program using a method of mediated learning while the Control Group will participate in a program of the Adler Institute involving activities aimed at social and emotional development without specific cognitive skill training.
|Condition or disease||Intervention/treatment||Phase|
|Mild Cognitive Impairment||Behavioral: Feuerstein Program Behavioral: Adler Program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||26 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||An Evaluation of the Feuerstein Instrumental Enrichment Program for the Cognitive Enhancement of Older People With Mild Cognitive Impairment (MCI) Living in the Community|
|Actual Study Start Date :||September 3, 2015|
|Actual Primary Completion Date :||May 31, 2016|
|Actual Study Completion Date :||May 31, 2016|
Active Comparator: Feuerstein Program
The participants of the Intervention Group will participate in the Feuerstein mediated learning cognitive program.
Behavioral: Feuerstein Program
Mediated learning cognitive enhancement program
Placebo Comparator: Adler Program
The Control Group will participate in the program of the Adler Institute dealing with social and emotional development without specific cognitive skills training.
Behavioral: Adler Program
Social and emotional group program
- Change from baseline cognitive function [ Time Frame: Through study completion, an average of 6 months ]Based on Neurotrax computerized neuropsychological assessment battery
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||60 Years and older (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
- Aged 60 and above.
- Hebrew/English speakers.
- Expressing willingness to participate in the research and deliberately signing a consent form.
- A diagnosis of MCI exists according to accepted clinical criteria - the examinee's score in the MoCA Test is within the range of 18-26 (inclusive).
- A medical or functional condition that will not allow the patient to participate in the intervention program within the research period.
- Diagnosed patients suffering from depression, bipolar disorder or schizophrenia.
- Patients who suffer from a diagnosed cognitive impairment other than MCI (delirium dementia or mental retardation).
- Visual impairment that hasn't been amended by glasses.
- Hearing impairment that hasn't been amended by a hearing aid.
- Examinees whose MoCA Test's score is 17 and below or 27 and above.
- Examinees who will receive the maximal score in one or more sections of the Lawton Test.
- Examinees who will respond positively to a filter question regarding the topic of depression.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02774083
|Ramat Tamir Retirement Home|
|Jerusalem, Israel, 91450|
|Beit Tovei Hair|
|Jerusalem, Israel, 9550100|
|Bayit Balev Beit Ildan|
|Qiryat Moẕqin, Israel, 2640143|
|Bayit Balev Tel Aviv|
|Tel Aviv, Israel|
|Principal Investigator:||Tzvi Dwolatzky, MD MBBCh||Rambam Health Care Campus|
|Responsible Party:||Tzvi Dwolatzky, Prof. Tzvi Dwolatzky, Rambam Health Care Campus|
|Other Study ID Numbers:||
|First Posted:||May 17, 2016 Key Record Dates|
|Last Update Posted:||September 24, 2019|
|Last Verified:||September 2019|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|